Pathological Response and Circulating Tumor Cell Count Identifies Treated HER2+ Inflammatory Breast Cancer Patients with Excellent Prognosis: BEVERLY-2 Survival Data-Reference-Cited by-同舟云学术

Pathological Response and Circulating Tumor Cell Count Identifies Treated HER2+ Inflammatory Breast Cancer Patients with Excellent Prognosis: BEVERLY-2 Survival Data

Published:2014-12-23 Issue:6 Volume:21 Page:1298-1304
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Pierga Jean-Yves,Petit Thierry,Lévy Christelle,Ferrero Jean-Marc,Campone Mario,Gligorov Joseph,Lerebours Florence,Roché Henri,Bachelot Thomas,Charafe-Jauffret Emmanuelle,Bonneterre Jacques,Hernandez Juana,Bidard François-Clément,Viens Patrice

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors;Critical Reviews in Oncology/Hematology;2024-11

2. Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine;Current Opinion in Oncology;2024-07-16

3. Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells;International Journal of Molecular Sciences;2024-04-29

4. Factors influencing the diagnostic and prognostic values of circulating tumor cells in breast cancer: a meta-analysis of 8,935 patients;Frontiers in Oncology;2023-11-27

5. Clinical Applications for Liquid Biopsy Assessment of Minimal Residual Disease in Breast Cancer;Current Breast Cancer Reports;2023-05-12